Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | LB101 |
Synonyms | |
Therapy Description |
LB101 is a conditionally activated bispecific antibody targeting both CD47 and PD-L1 (CD274), which may promote antibody-dependent cellular phagocytosis in PD-L1 (CD274)-positive tumor microenvironment (J Clin Oncol 40, no. 16_suppl (June 01, 2022) 2562). |